{"entity":{"type":"insider","cik":"0001401018","url":"/insider/0001401018","json_url":"/insider/0001401018.json","name":"Patterson Matthew R","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":122,"n_filings":23,"first":"2008-04-16","last":"2019-11-12","span_basis":"filed_date"},"name_variants":[{"name":"Patterson Matthew R","source":"filing","n_filings":23,"first_seen":"2008-04-16","last_seen":"2019-11-12"}],"transactions":[{"id":8520272,"accession":"0001209191-19-056113","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-19-056113","line_url":"/filing/0001209191-19-056113#line-2","is_derivative":false,"issuer_cik":"0001401018","issuer_name":"Audentes Therapeutics, Inc.","issuer_ticker":"BOLD","issuer_name_source":null,"issuer_url":"/issuer/0001401018","owner_cik":"0001401018","owner_name":"Patterson Matthew R","owner_display_name":"Patterson Matthew R","owner_url":"/insider/0001401018","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":14426.0,"shares_display":"14,426","price_per_share":30.0,"price_display":"30.00","price_state":"stated","total_value":432780.0,"total_display":"432,780.00","total_whole":"432,780","shares_owned_after":113394.0,"shares_owned_after_display":"113,394","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-11-08","filed_date":"2019-11-12","scope":"insider"},{"id":8728189,"accession":"0001209191-19-046001","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-19-046001","line_url":"/filing/0001209191-19-046001","is_derivative":false,"issuer_cik":"0001401018","issuer_name":"Audentes Therapeutics, Inc.","issuer_ticker":"BOLD","issuer_name_source":null,"issuer_url":"/issuer/0001401018","owner_cik":"0001401018","owner_name":"Patterson Matthew R","owner_display_name":"Patterson Matthew R","owner_url":"/insider/0001401018","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":20000.0,"shares_display":"20,000","price_per_share":34.041735,"price_display":"34.04","price_state":"stated","total_value":680834.7,"total_display":"680,834.70","total_whole":"680,835","shares_owned_after":116368.0,"shares_owned_after_display":"116,368","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-08-12","filed_date":"2019-08-14","scope":"insider","n_lines":2},{"id":8597332,"accession":"0001209191-19-014072","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-19-014072","line_url":"/filing/0001209191-19-014072","is_derivative":false,"issuer_cik":"0001401018","issuer_name":"Audentes Therapeutics, Inc.","issuer_ticker":"BOLD","issuer_name_source":null,"issuer_url":"/issuer/0001401018","owner_cik":"0001401018","owner_name":"Patterson Matthew R","owner_display_name":"Patterson Matthew R","owner_url":"/insider/0001401018","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":21000.0,"shares_display":"21,000","price_per_share":30.0,"price_display":"30.00","price_state":"stated","total_value":630000.0,"total_display":"630,000.00","total_whole":"630,000","shares_owned_after":118700.0,"shares_owned_after_display":"118,700","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-02-25","filed_date":"2019-02-27","scope":"insider","n_lines":2},{"id":6456229,"accession":"0001209191-18-053466","txn_seq":8,"anchor":"line-8","filing_url":"/filing/0001209191-18-053466","line_url":"/filing/0001209191-18-053466","is_derivative":false,"issuer_cik":"0001401018","issuer_name":"Audentes Therapeutics, Inc.","issuer_ticker":"BOLD","issuer_name_source":null,"issuer_url":"/issuer/0001401018","owner_cik":"0001401018","owner_name":"Patterson Matthew R","owner_display_name":"Patterson Matthew R","owner_url":"/insider/0001401018","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":21000.0,"shares_display":"21,000","price_per_share":38.160584761904765,"price_display":"38.16","price_state":"stated","total_value":801372.28,"total_display":"801,372.28","total_whole":"801,372","shares_owned_after":15000.0,"shares_owned_after_display":"15,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-10-01","filed_date":"2018-10-02","scope":"insider","n_lines":4},{"id":5966053,"accession":"0001209191-18-051837","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-18-051837","line_url":"/filing/0001209191-18-051837#line-2","is_derivative":false,"issuer_cik":"0001401018","issuer_name":"Audentes Therapeutics, Inc.","issuer_ticker":"BOLD","issuer_name_source":null,"issuer_url":"/issuer/0001401018","owner_cik":"0001401018","owner_name":"Patterson Matthew R","owner_display_name":"Patterson Matthew R","owner_url":"/insider/0001401018","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":12952.0,"shares_display":"12,952","price_per_share":40.0,"price_display":"40.00","price_state":"stated","total_value":518080.0,"total_display":"518,080.00","total_whole":"518,080","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-09-18","filed_date":"2018-09-20","scope":"insider"},{"id":6803102,"accession":"0001209191-18-041768","txn_seq":8,"anchor":"line-8","filing_url":"/filing/0001209191-18-041768","line_url":"/filing/0001209191-18-041768#line-8","is_derivative":false,"issuer_cik":"0001401018","issuer_name":"Audentes Therapeutics, Inc.","issuer_ticker":"BOLD","issuer_name_source":null,"issuer_url":"/issuer/0001401018","owner_cik":"0001401018","owner_name":"Patterson Matthew R","owner_display_name":"Patterson Matthew R","owner_url":"/insider/0001401018","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":23147.0,"shares_display":"23,147","price_per_share":40.042,"price_display":"40.04","price_state":"stated","total_value":926852.174,"total_display":"926,852.17","total_whole":"926,852","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-07-05","filed_date":"2018-07-05","scope":"insider"},{"id":6803094,"accession":"0001209191-18-041768","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001209191-18-041768","line_url":"/filing/0001209191-18-041768#line-6","is_derivative":false,"issuer_cik":"0001401018","issuer_name":"Audentes Therapeutics, Inc.","issuer_ticker":"BOLD","issuer_name_source":null,"issuer_url":"/issuer/0001401018","owner_cik":"0001401018","owner_name":"Patterson Matthew R","owner_display_name":"Patterson Matthew R","owner_url":"/insider/0001401018","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":26901.0,"shares_display":"26,901","price_per_share":40.0528,"price_display":"40.05","price_state":"stated","total_value":1077460.3728,"total_display":"1,077,460.37","total_whole":"1,077,460","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-07-03","filed_date":"2018-07-05","scope":"insider"},{"id":6803080,"accession":"0001209191-18-041768","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-18-041768","line_url":"/filing/0001209191-18-041768","is_derivative":false,"issuer_cik":"0001401018","issuer_name":"Audentes Therapeutics, Inc.","issuer_ticker":"BOLD","issuer_name_source":null,"issuer_url":"/issuer/0001401018","owner_cik":"0001401018","owner_name":"Patterson Matthew R","owner_display_name":"Patterson Matthew R","owner_url":"/insider/0001401018","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":21000.0,"shares_display":"21,000","price_per_share":38.35829481428571,"price_display":"38.36","price_state":"stated","total_value":805524.1911,"total_display":"805,524.19","total_whole":"805,524","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-07-02","filed_date":"2018-07-05","scope":"insider","n_lines":2},{"id":6146719,"accession":"0001209191-18-032716","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-18-032716","line_url":"/filing/0001209191-18-032716","is_derivative":false,"issuer_cik":"0001401018","issuer_name":"Audentes Therapeutics, Inc.","issuer_ticker":"BOLD","issuer_name_source":null,"issuer_url":"/issuer/0001401018","owner_cik":"0001401018","owner_name":"Patterson Matthew R","owner_display_name":"Patterson Matthew R","owner_url":"/insider/0001401018","role":"Director, Officer (President & CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President & CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":20300.0,"shares_display":"20,300","price_per_share":38.152610837438424,"price_display":"38.15","price_state":"stated","total_value":774498.0,"total_display":"774,498.00","total_whole":"774,498","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-05-21","filed_date":"2018-05-23","scope":"insider","n_lines":2},{"id":6043361,"accession":"0001209191-18-023956","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-18-023956","line_url":"/filing/0001209191-18-023956#line-2","is_derivative":false,"issuer_cik":"0001401018","issuer_name":"Audentes Therapeutics, Inc.","issuer_ticker":"BOLD","issuer_name_source":null,"issuer_url":"/issuer/0001401018","owner_cik":"0001401018","owner_name":"Patterson Matthew R","owner_display_name":"Patterson Matthew R","owner_url":"/insider/0001401018","role":"Director, Officer (President & CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President & CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":700.0,"shares_display":"700","price_per_share":30.0129,"price_display":"30.01","price_state":"stated","total_value":21009.03,"total_display":"21,009.03","total_whole":"21,009","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-04-02","filed_date":"2018-04-04","scope":"insider"},{"id":5071917,"accession":"0001209191-17-056048","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-17-056048","line_url":"/filing/0001209191-17-056048","is_derivative":false,"issuer_cik":"0001401018","issuer_name":"Audentes Therapeutics, Inc.","issuer_ticker":"BOLD","issuer_name_source":null,"issuer_url":"/issuer/0001401018","owner_cik":"0001401018","owner_name":"Patterson Matthew R","owner_display_name":"Patterson Matthew R","owner_url":"/insider/0001401018","role":"Director, Officer (President & CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President & CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":25000.0,"shares_display":"25,000","price_per_share":27.92278,"price_display":"27.92","price_state":"stated","total_value":698069.5,"total_display":"698,069.50","total_whole":"698,070","shares_owned_after":171814.0,"shares_owned_after_display":"171,814","ownership_form":"I","is_10b5_1":null,"transaction_date":"2017-10-02","filed_date":"2017-10-04","scope":"insider","n_lines":2},{"id":4268427,"accession":"0001209191-17-053351","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-17-053351","line_url":"/filing/0001209191-17-053351#line-4","is_derivative":false,"issuer_cik":"0001401018","issuer_name":"Audentes Therapeutics, Inc.","issuer_ticker":"BOLD","issuer_name_source":null,"issuer_url":"/issuer/0001401018","owner_cik":"0001401018","owner_name":"Patterson Matthew R","owner_display_name":"Patterson Matthew R","owner_url":"/insider/0001401018","role":"Director, Officer (President & CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President & CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":8458.0,"shares_display":"8,458","price_per_share":25.0662,"price_display":"25.07","price_state":"stated","total_value":212009.9196,"total_display":"212,009.92","total_whole":"212,010","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-09-18","filed_date":"2017-09-19","scope":"insider"},{"id":4268422,"accession":"0001209191-17-053351","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-17-053351","line_url":"/filing/0001209191-17-053351#line-2","is_derivative":false,"issuer_cik":"0001401018","issuer_name":"Audentes Therapeutics, Inc.","issuer_ticker":"BOLD","issuer_name_source":null,"issuer_url":"/issuer/0001401018","owner_cik":"0001401018","owner_name":"Patterson Matthew R","owner_display_name":"Patterson Matthew R","owner_url":"/insider/0001401018","role":"Director, Officer (President & CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President & CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1542.0,"shares_display":"1,542","price_per_share":25.0006,"price_display":"25.00","price_state":"stated","total_value":38550.9252,"total_display":"38,550.93","total_whole":"38,551","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-09-15","filed_date":"2017-09-19","scope":"insider"},{"id":5120275,"accession":"0001209191-17-045270","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-17-045270","line_url":"/filing/0001209191-17-045270#line-2","is_derivative":false,"issuer_cik":"0001401018","issuer_name":"Audentes Therapeutics, Inc.","issuer_ticker":"BOLD","issuer_name_source":null,"issuer_url":"/issuer/0001401018","owner_cik":"0001401018","owner_name":"Patterson Matthew R","owner_display_name":"Patterson Matthew R","owner_url":"/insider/0001401018","role":"Director, Officer (President & CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President & CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":12150.0,"shares_display":"12,150","price_per_share":20.0043,"price_display":"20.00","price_state":"stated","total_value":243052.245,"total_display":"243,052.24","total_whole":"243,052","shares_owned_after":186814.0,"shares_owned_after_display":"186,814","ownership_form":"I","is_10b5_1":null,"transaction_date":"2017-07-13","filed_date":"2017-07-14","scope":"insider"},{"id":5120268,"accession":"0001209191-17-045270","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-17-045270","line_url":"/filing/0001209191-17-045270#line-1","is_derivative":false,"issuer_cik":"0001401018","issuer_name":"Audentes Therapeutics, Inc.","issuer_ticker":"BOLD","issuer_name_source":null,"issuer_url":"/issuer/0001401018","owner_cik":"0001401018","owner_name":"Patterson Matthew R","owner_display_name":"Patterson Matthew R","owner_url":"/insider/0001401018","role":"Director, Officer (President & CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President & CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2850.0,"shares_display":"2,850","price_per_share":20.0025,"price_display":"20.00","price_state":"stated","total_value":57007.125,"total_display":"57,007.12","total_whole":"57,007","shares_owned_after":198964.0,"shares_owned_after_display":"198,964","ownership_form":"I","is_10b5_1":null,"transaction_date":"2017-07-12","filed_date":"2017-07-14","scope":"insider"},{"id":3862824,"accession":"0001209191-08-058297","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-08-058297","line_url":"/filing/0001209191-08-058297#line-2","is_derivative":false,"issuer_cik":"0001178879","issuer_name":"AMICUS THERAPEUTICS INC","issuer_ticker":"FOLD","issuer_name_source":null,"issuer_url":"/issuer/0001178879","owner_cik":"0001401018","owner_name":"Patterson Matthew R","owner_display_name":"Patterson Matthew R","owner_url":"/insider/0001401018","role":"Officer (Chief Operating Officer)","role_mark":"O","role_mark_label":"Officer (Chief Operating Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Operating Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1939.0,"shares_display":"1,939","price_per_share":10.0,"price_display":"10.00","price_state":"stated","total_value":19390.0,"total_display":"19,390.00","total_whole":"19,390","shares_owned_after":36449.0,"shares_owned_after_display":"36,449","ownership_form":"D","is_10b5_1":null,"transaction_date":"2008-10-31","filed_date":"2008-11-03","scope":"insider"},{"id":3862822,"accession":"0001209191-08-058297","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-08-058297","line_url":"/filing/0001209191-08-058297#line-1","is_derivative":false,"issuer_cik":"0001178879","issuer_name":"AMICUS THERAPEUTICS INC","issuer_ticker":"FOLD","issuer_name_source":null,"issuer_url":"/issuer/0001178879","owner_cik":"0001401018","owner_name":"Patterson Matthew R","owner_display_name":"Patterson Matthew R","owner_url":"/insider/0001401018","role":"Officer (Chief Operating Officer)","role_mark":"O","role_mark_label":"Officer (Chief Operating Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Operating Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":361.0,"shares_display":"361","price_per_share":10.0,"price_display":"10.00","price_state":"stated","total_value":3610.0,"total_display":"3,610.00","total_whole":"3,610","shares_owned_after":38388.0,"shares_owned_after_display":"38,388","ownership_form":"D","is_10b5_1":null,"transaction_date":"2008-10-30","filed_date":"2008-11-03","scope":"insider"},{"id":3894373,"accession":"0001209191-08-057418","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-08-057418","line_url":"/filing/0001209191-08-057418#line-2","is_derivative":false,"issuer_cik":"0001178879","issuer_name":"AMICUS THERAPEUTICS INC","issuer_ticker":"FOLD","issuer_name_source":null,"issuer_url":"/issuer/0001178879","owner_cik":"0001401018","owner_name":"Patterson Matthew R","owner_display_name":"Patterson Matthew R","owner_url":"/insider/0001401018","role":"Officer (Chief Operating Officer)","role_mark":"O","role_mark_label":"Officer (Chief Operating Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Operating Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":100.0,"shares_display":"100","price_per_share":10.1,"price_display":"10.10","price_state":"stated","total_value":1010.0,"total_display":"1,010.00","total_whole":"1,010","shares_owned_after":38749.0,"shares_owned_after_display":"38,749","ownership_form":"D","is_10b5_1":null,"transaction_date":"2008-10-23","filed_date":"2008-10-24","scope":"insider"},{"id":3894371,"accession":"0001209191-08-057418","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-08-057418","line_url":"/filing/0001209191-08-057418#line-1","is_derivative":false,"issuer_cik":"0001178879","issuer_name":"AMICUS THERAPEUTICS INC","issuer_ticker":"FOLD","issuer_name_source":null,"issuer_url":"/issuer/0001178879","owner_cik":"0001401018","owner_name":"Patterson Matthew R","owner_display_name":"Patterson Matthew R","owner_url":"/insider/0001401018","role":"Officer (Chief Operating Officer)","role_mark":"O","role_mark_label":"Officer (Chief Operating Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Operating Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3100.0,"shares_display":"3,100","price_per_share":10.402,"price_display":"10.40","price_state":"stated","total_value":32246.2,"total_display":"32,246.20","total_whole":"32,246","shares_owned_after":38849.0,"shares_owned_after_display":"38,849","ownership_form":"D","is_10b5_1":null,"transaction_date":"2008-10-22","filed_date":"2008-10-24","scope":"insider"},{"id":4038162,"accession":"0001209191-08-057208","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-08-057208","line_url":"/filing/0001209191-08-057208#line-3","is_derivative":false,"issuer_cik":"0001178879","issuer_name":"AMICUS THERAPEUTICS INC","issuer_ticker":"FOLD","issuer_name_source":null,"issuer_url":"/issuer/0001178879","owner_cik":"0001401018","owner_name":"Patterson Matthew R","owner_display_name":"Patterson Matthew R","owner_url":"/insider/0001401018","role":"Officer (Chief Operating Officer)","role_mark":"O","role_mark_label":"Officer (Chief Operating Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Operating Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2500.0,"shares_display":"2,500","price_per_share":10.505,"price_display":"10.50","price_state":"stated","total_value":26262.5,"total_display":"26,262.50","total_whole":"26,263","shares_owned_after":41949.0,"shares_owned_after_display":"41,949","ownership_form":"D","is_10b5_1":null,"transaction_date":"2008-10-21","filed_date":"2008-10-22","scope":"insider"},{"id":4038160,"accession":"0001209191-08-057208","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-08-057208","line_url":"/filing/0001209191-08-057208","is_derivative":false,"issuer_cik":"0001178879","issuer_name":"AMICUS THERAPEUTICS INC","issuer_ticker":"FOLD","issuer_name_source":null,"issuer_url":"/issuer/0001178879","owner_cik":"0001401018","owner_name":"Patterson Matthew R","owner_display_name":"Patterson Matthew R","owner_url":"/insider/0001401018","role":"Officer (Chief Operating Officer)","role_mark":"O","role_mark_label":"Officer (Chief Operating Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Operating Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2000.0,"shares_display":"2,000","price_per_share":10.77185,"price_display":"10.77","price_state":"stated","total_value":21543.7,"total_display":"21,543.70","total_whole":"21,544","shares_owned_after":44549.0,"shares_owned_after_display":"44,549","ownership_form":"D","is_10b5_1":null,"transaction_date":"2008-10-20","filed_date":"2008-10-22","scope":"insider","n_lines":2},{"id":3805688,"accession":"0001209191-08-048638","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-08-048638","line_url":"/filing/0001209191-08-048638#line-1","is_derivative":false,"issuer_cik":"0001178879","issuer_name":"AMICUS THERAPEUTICS INC","issuer_ticker":"FOLD","issuer_name_source":null,"issuer_url":"/issuer/0001178879","owner_cik":"0001401018","owner_name":"Patterson Matthew R","owner_display_name":"Patterson Matthew R","owner_url":"/insider/0001401018","role":"Officer (Chief Operating Officer)","role_mark":"O","role_mark_label":"Officer (Chief Operating Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Operating Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2000.0,"shares_display":"2,000","price_per_share":13.535,"price_display":"13.54","price_state":"stated","total_value":27070.0,"total_display":"27,070.00","total_whole":"27,070","shares_owned_after":46449.0,"shares_owned_after_display":"46,449","ownership_form":"D","is_10b5_1":null,"transaction_date":"2008-08-20","filed_date":"2008-08-21","scope":"insider"},{"id":3970521,"accession":"0001209191-08-048430","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-08-048430","line_url":"/filing/0001209191-08-048430","is_derivative":false,"issuer_cik":"0001178879","issuer_name":"AMICUS THERAPEUTICS INC","issuer_ticker":"FOLD","issuer_name_source":null,"issuer_url":"/issuer/0001178879","owner_cik":"0001401018","owner_name":"Patterson Matthew R","owner_display_name":"Patterson Matthew R","owner_url":"/insider/0001401018","role":"Officer (Chief Operating Officer)","role_mark":"O","role_mark_label":"Officer (Chief Operating Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Operating Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4500.0,"shares_display":"4,500","price_per_share":13.831888888888889,"price_display":"13.83","price_state":"stated","total_value":62243.5,"total_display":"62,243.50","total_whole":"62,244","shares_owned_after":49149.0,"shares_owned_after_display":"49,149","ownership_form":"D","is_10b5_1":null,"transaction_date":"2008-08-19","filed_date":"2008-08-20","scope":"insider","n_lines":2},{"id":3970518,"accession":"0001209191-08-048430","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-08-048430","line_url":"/filing/0001209191-08-048430","is_derivative":false,"issuer_cik":"0001178879","issuer_name":"AMICUS THERAPEUTICS INC","issuer_ticker":"FOLD","issuer_name_source":null,"issuer_url":"/issuer/0001178879","owner_cik":"0001401018","owner_name":"Patterson Matthew R","owner_display_name":"Patterson Matthew R","owner_url":"/insider/0001401018","role":"Officer (Chief Operating Officer)","role_mark":"O","role_mark_label":"Officer (Chief Operating Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Operating Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3500.0,"shares_display":"3,500","price_per_share":15.25382857142857,"price_display":"15.25","price_state":"stated","total_value":53388.4,"total_display":"53,388.40","total_whole":"53,388","shares_owned_after":53749.0,"shares_owned_after_display":"53,749","ownership_form":"D","is_10b5_1":null,"transaction_date":"2008-08-18","filed_date":"2008-08-20","scope":"insider","n_lines":2},{"id":9265640,"accession":"0001209191-08-043235","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-08-043235","line_url":"/filing/0001209191-08-043235","is_derivative":false,"issuer_cik":"0001401018","issuer_name":"AMICUS THERAPEUTICS INC","issuer_ticker":"[FOLD]","issuer_name_source":null,"issuer_url":"/issuer/0001401018","owner_cik":"0001401018","owner_name":"Patterson Matthew R","owner_display_name":"Patterson Matthew R","owner_url":"/insider/0001401018","role":"Officer (Chief Operating Officer)","role_mark":"O","role_mark_label":"Officer (Chief Operating Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Operating Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1000.0,"shares_display":"1,000","price_per_share":11.34123,"price_display":"11.34","price_state":"stated","total_value":11341.23,"total_display":"11,341.23","total_whole":"11,341","shares_owned_after":56849.0,"shares_owned_after_display":"56,849","ownership_form":"D","is_10b5_1":null,"transaction_date":"2008-06-20","filed_date":"2008-07-22","scope":"insider","n_lines":4},{"id":9265637,"accession":"0001209191-08-043235","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001209191-08-043235","line_url":"/filing/0001209191-08-043235#line-5","is_derivative":false,"issuer_cik":"0001401018","issuer_name":"AMICUS THERAPEUTICS INC","issuer_ticker":"[FOLD]","issuer_name_source":null,"issuer_url":"/issuer/0001401018","owner_cik":"0001401018","owner_name":"Patterson Matthew R","owner_display_name":"Patterson Matthew R","owner_url":"/insider/0001401018","role":"Officer (Chief Operating Officer)","role_mark":"O","role_mark_label":"Officer (Chief Operating Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Operating Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":400.0,"shares_display":"400","price_per_share":11.54,"price_display":"11.54","price_state":"stated","total_value":4616.0,"total_display":"4,616.00","total_whole":"4,616","shares_owned_after":56449.0,"shares_owned_after_display":"56,449","ownership_form":"D","is_10b5_1":null,"transaction_date":"2008-06-20","filed_date":"2008-07-22","scope":"insider"},{"id":3858552,"accession":"0001209191-08-038600","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001209191-08-038600","line_url":"/filing/0001209191-08-038600","is_derivative":false,"issuer_cik":"0001178879","issuer_name":"AMICUS THERAPEUTICS INC","issuer_ticker":"FOLD","issuer_name_source":null,"issuer_url":"/issuer/0001178879","owner_cik":"0001401018","owner_name":"Patterson Matthew R","owner_display_name":"Patterson Matthew R","owner_url":"/insider/0001401018","role":"Officer (Chief Operating Officer)","role_mark":"O","role_mark_label":"Officer (Chief Operating Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Operating Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1400.0,"shares_display":"1,400","price_per_share":11.398021428571429,"price_display":"11.40","price_state":"stated","total_value":15957.23,"total_display":"15,957.23","total_whole":"15,957","shares_owned_after":58549.0,"shares_owned_after_display":"58,549","ownership_form":"D","is_10b5_1":null,"transaction_date":"2008-06-20","filed_date":"2008-06-24","scope":"insider","n_lines":5},{"id":9265647,"accession":"0001209191-08-043236","txn_seq":8,"anchor":"line-8","filing_url":"/filing/0001209191-08-043236","line_url":"/filing/0001209191-08-043236","is_derivative":false,"issuer_cik":"0001401018","issuer_name":"AMICUS THERAPEUTICS INC","issuer_ticker":"[FOLD]","issuer_name_source":null,"issuer_url":"/issuer/0001401018","owner_cik":"0001401018","owner_name":"Patterson Matthew R","owner_display_name":"Patterson Matthew R","owner_url":"/insider/0001401018","role":"Officer (Chief Operating Officer)","role_mark":"O","role_mark_label":"Officer (Chief Operating Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Operating Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":400.0,"shares_display":"400","price_per_share":11.03065,"price_display":"11.03","price_state":"stated","total_value":4412.26,"total_display":"4,412.26","total_whole":"4,412","shares_owned_after":58163.0,"shares_owned_after_display":"58,163","ownership_form":"D","is_10b5_1":null,"transaction_date":"2008-06-19","filed_date":"2008-07-22","scope":"insider","n_lines":3},{"id":3612938,"accession":"0001209191-08-038214","txn_seq":10,"anchor":"line-10","filing_url":"/filing/0001209191-08-038214","line_url":"/filing/0001209191-08-038214#line-10","is_derivative":false,"issuer_cik":"0001178879","issuer_name":"AMICUS THERAPEUTICS INC","issuer_ticker":"FOLD","issuer_name_source":null,"issuer_url":"/issuer/0001178879","owner_cik":"0001401018","owner_name":"Patterson Matthew R","owner_display_name":"Patterson Matthew R","owner_url":"/insider/0001401018","role":"Officer (Chief Operating Officer)","role_mark":"O","role_mark_label":"Officer (Chief Operating Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Operating Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":300.0,"shares_display":"300","price_per_share":11.03,"price_display":"11.03","price_state":"stated","total_value":3309.0,"total_display":"3,309.00","total_whole":"3,309","shares_owned_after":59963.0,"shares_owned_after_display":"59,963","ownership_form":"D","is_10b5_1":null,"transaction_date":"2008-06-19","filed_date":"2008-06-20","scope":"insider"},{"id":3612935,"accession":"0001209191-08-038214","txn_seq":9,"anchor":"line-9","filing_url":"/filing/0001209191-08-038214","line_url":"/filing/0001209191-08-038214#line-9","is_derivative":false,"issuer_cik":"0001178879","issuer_name":"AMICUS THERAPEUTICS INC","issuer_ticker":"FOLD","issuer_name_source":null,"issuer_url":"/issuer/0001178879","owner_cik":"0001401018","owner_name":"Patterson Matthew R","owner_display_name":"Patterson Matthew R","owner_url":"/insider/0001401018","role":"Officer (Chief Operating Officer)","role_mark":"O","role_mark_label":"Officer (Chief Operating Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Operating Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":86.0,"shares_display":"86","price_per_share":11.02,"price_display":"11.02","price_state":"stated","total_value":947.72,"total_display":"947.72","total_whole":"948","shares_owned_after":60263.0,"shares_owned_after_display":"60,263","ownership_form":"D","is_10b5_1":null,"transaction_date":"2008-06-19","filed_date":"2008-06-20","scope":"insider"}],"collapsed":true,"next_cursor":"2008-06-19|3612935","ledger_fault":false,"count":{"value":122,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":122,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":122},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001628738","name":"Audentes Therapeutics, Inc.","url":"/issuer/0001628738","role":"Director, Officer (Chief Executive Officer)","n_filings":11,"first_seen":"2017-07-14","last_seen":"2019-11-12"},{"type":"issuer","type_label":"ISSUER","cik":"0001178879","name":"AMICUS THERAPEUTICS INC","url":"/issuer/0001178879","role":"Officer (Chief Operating Officer)","n_filings":12,"first_seen":"2008-04-16","last_seen":"2008-11-03"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001401018","retrieved_at":"2026-08-22T09:24:00+00:00","coverage":{"filings":1505395,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}